Search
Xtant Medical Holdings Inc
XTNTAdd to Watchlist
0.420USD
-0.001-0.24%
Close 07/01, 16:00（ET）Quotes delayed by 15 min
58.91MMarket Cap
31.91P/E TTM
View Detailed Chart
TradingKey 图表Intraday
1m
30m
1h
D
W
M
D
Today
-0.24%
5 Days
-2.33%
1 Month
-9.13%
6 Months
-46.43%
Year to Date
-46.43%
1 Year
-41.26%
Key Figures
0.430Open
0.438High
58.83KVolume
31.91P/E TTM
LossP/E Dynamic
--Dividend TTM
0.04%Turnover Ratio
0.421Prev. Close
0.420Low
19.90KTurnover
LossP/E Static
1.15P/B
0.00%Div Yield TTM
2.10%ROA
0.95052wk High
1.57Volume Ratio
-16.45MNet Profit
140.04MShares
0.0132EPS TTM
-0.15Beta
3.95%ROE
0.43852wk Low
4.25%Amplitude
57.32%Gross Margin
58.91MMarket Cap
-2.41Reward/Risk
3.92%Risk Rate
TradingKey Stock Score of Xtant Medical Holdings Inc
Currency: USD Updated: 2026-07-01Key Insights
Xtant Medical Holdings Inc's fundamentals are relatively very healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 82 out of 204 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 1.23.In the medium term, the stock price is expected to remain stable.Despite a weak stock market performance over the past month, the company shows strong fundamentals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Xtant Medical Holdings Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Xtant Medical Holdings Inc Highlights
StrengthsRisks
Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoVive, OsteoFactor, line of 3Demin products, as well as other allografts. It offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical products, Thoracolumbar products, Sacroiliac Joint products, Interbody products and Interlaminar Stabilization products.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 46.68% year-on-year.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 133.93M.
Turnaround to Profit
The company's performance has turned profitable, with the latest annual net income of USD .
Fairly Valued
The company’s latest PE is 31.91, at a medium 3-year percentile range.
Held by James Simons
Star Investor James Simons holds 0.00 shares of this stock.
Lower Market Activity
The company has less investor interest, with a 20-day turnover ratio of -0.42.
Analyst Rating
Based on
3
analysts
Buy
Current Rating
1.233
Target Price
+192.95%
Upside Space
Xtant Medical Holdings Inc News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Xtant Medical Holdings Inc Info
Xtant Medical Holdings, Inc. is a global medical technology company. The Company is focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant fixation systems to facilitate spinal fusion in complex spine, deformity, and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. Its biomaterial products include OsteoSponge, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, OsteoVive, OsteoFactor, line of 3Demin products, as well as other allografts. It offers a comprehensive line of products that are used to treat a variety of spinal and sacroiliac conditions, including trauma, degeneration, deformity and tumor. Its key spinal implant product lines include Cervical products, Thoracolumbar products, Sacroiliac Joint products, Interbody products and Interlaminar Stabilization products.
Ticker SymbolXTNT
CompanyXtant Medical Holdings Inc
CEOBrowne (Sean E)
Websitehttps://xtantmedical.com/
Related Instruments
+2.62%
+2.41%
+1.57%
+1.18%
+1.73%
+1.30%
-0.50%
+1.27%
+7.60%
+0.88%
+0.39%
+0.89%
+1.92%
+1.70%
+5.81%
+3.09%
+2.12%
+1.08%
+1.78%
+0.41%Popular Instruments
52341.700
+87.400 (+0.17%)
29674.700
-124.600 (-0.42%)
7476.900
+1.400 (+0.02%)
14748.000
-607.000 (-3.95%)
68681.000
-804.000 (-1.16%)
6304.000
+28.600 (+0.46%)
67.424
-0.544 (-0.80%)
294.380
+5.020 (+1.73%)
197.580
-2.510 (-1.25%)
4064.010
+33.240 (+0.82%)
FAQs
What is the current price of Xtant Medical Holdings Inc (XTNT)?
The current price of Xtant Medical Holdings Inc (XTNT) is 0.42.
What is the symbol of Xtant Medical Holdings Inc?
The ticker symbol of Xtant Medical Holdings Inc is XTNT.
What is the 52-week high of Xtant Medical Holdings Inc?
The 52-week high of Xtant Medical Holdings Inc is 0.95.
What is the 52-week low of Xtant Medical Holdings Inc?
The 52-week low of Xtant Medical Holdings Inc is 0.44.
What is the market capitalization of Xtant Medical Holdings Inc?
The market capitalization of Xtant Medical Holdings Inc is 58.82M.
Is Xtant Medical Holdings Inc (XTNT) currently rated as Buy, Hold, or Sell?
According to analysts, Xtant Medical Holdings Inc (XTNT) has an overall rating of Buy, with a price target of 1.23.
What is the Earnings Per Share (EPS TTM) of Xtant Medical Holdings Inc (XTNT)?
The Earnings Per Share (EPS TTM) of Xtant Medical Holdings Inc (XTNT) is 0.04.